This inventor holds 4 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1993-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1997
Title: David E Clarke: Innovator in Pharmaceutical Chemistry
Introduction
David E Clarke is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to his name, Clarke's work has had a meaningful impact on the industry.
Latest Patents
Clarke's latest patents include innovative compounds such as 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine. This invention relates to novel α1-adrenoceptor antagonists of a specific formula, which are designed to provide therapeutic benefits. Another significant patent involves N-aryloxyalkyl tryptamine α1-adrenergic receptor antagonists, which also follow a defined formula and have various applications in medicine.
Career Highlights
David E Clarke has been associated with Syntex (U.S.A.) Inc., where he has played a crucial role in advancing pharmaceutical research and development. His expertise in creating new chemical entities has positioned him as a valuable asset in the field.
Collaborations
Clarke has collaborated with notable colleagues such as Robin D Clark and Lawrence Emerson Fisher. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
David E Clarke's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile